Generic Name and Formulations:
Dimenhydrinate 50mg; scored tabs.
McNeil Consumer Healthcare
Indications for DRAMAMINE:
Motion sickness prophylaxis.
50–100mg every 4–6 hours, starting ½–1 hour before travel; max 400mg/day.
<2 years: not recommended. 2–6 years: 12.5–25mg; max 75mg/day. 6–11 yrs: 25–50mg; max 150mg/day. Both: starting ½–1 hour before travel; may repeat every 6–8 hours.
Asthma or chronic respiratory disease. Glaucoma. Arrhythmias. GI or urinary obstruction. Phenylketonuria (chewable tabs). Pregnancy (Cat.B). Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants. May potentiate ototoxicity of antibiotics (esp. aminoglycosides).
Drowsiness, sedation, anticholinergic effects, paradoxical excitement in children.
Tabs—12, 36, 100
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Prioritizing Rest in Hospital Settings: Poor Sleep Increases Costs, Complications, and Mortality
- Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation
- Addressing Commercial Incentives in the Medical Device Industry
- Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances
- Low Literacy Self-Management Program for Chronic Pain May Be Effective